Case Study · Healthcare / Biotech
How GrowthSparx structured condition-aware messaging, geographic segmentation and cost discipline for a policy-restricted healthcare acquisition programme.
Client
Healthcare / Biotech
Published outcome
published average CPL
Evidence note
Historical result reproduced from the case information already present in the supplied website files; it is not a guarantee for another campaign.
The challenge
Advancells operates in a sensitive healthcare category where advertising policies restrict experimental and unapproved treatment claims. The supplied case record describes the need to generate worldwide patient enquiries without relying on prohibited keyword or claim routes.
The approach
Campaign angles emphasized awareness, education and consultation intent rather than restricted treatment promises.
Markets and relevant audience contexts were separated so performance and lead quality could be reviewed clearly.
The programme tested acquisition experiences while protecting claim discipline in a restricted category.
Published result
The existing published case record reports worldwide patient enquiries at an average cost per lead of approximately ₹40.
Transferable lesson
Restricted categories require marketing, policy, clinical and legal review to work together. Historical delivery does not remove the need to verify current platform policies and approved claims for every new campaign.
Explore the system
Data transparency
The supplied public record does not include the campaign period, spend, sample size, attribution window or source screenshots. Before using this outcome in proposals or adding more numbers, GrowthSparx should attach client-approved evidence and define every metric. Results vary by market, offer, budget, data quality and execution.
Book a free audit covering acquisition, conversion, CRM handoff and measurable sales outcomes.
Book a Free Growth AuditHave a question? Message us directly on WhatsApp—usually a reply within a few hours.
Chat on WhatsApp